Article
Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.
Diabetes care - 1 Aug 2009
Kumaraguru Janani, Flanagan Sarah E, Greeley Siri Atma W, Nuboer Roos, Støy Julie, Philipson Louis H, Hattersley Andrew T, Rubio-Cabezas Oscar
Abstract excerpt
OBJECTIVE To assess if tooth discoloration is a novel side effect of sulfonylurea therapy in patients with permanent neonatal diabetes due to mutations in KCNJ11. RESEARCH DESIGN AND METHODS A total of 67 patients with a known KCNJ11 mutation who had been successfully transferred from insulin injections onto oral sulfonylureas were contacted and asked about the development of tooth discoloration after transfer....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
